All NIH Funding Opportunities and Notices

• CONSIDERATIONS FOR RECIPIENTS OF NIH RESEARCH GRANTS AND CONTRACTS --RESPONSE TO COMMENTS
  (NOT-94-327)
  National Institutes of Health
  

• INCLUDING AIDS RESEARCH IN BEHAVIORAL THERAPIES DEVELOPMENT PROGRAM
  (NOT-94-328)
  National Institute on Drug Abuse
  

• NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES, EXTRAMURAL PROGRAMS
  (NOT-94-329)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• NCI BRIEFING ON PROSTATE SPORE PROGRAM
  (NOT-94-330)
  National Cancer Institute
  

• NIAID AWARD AND APPLICATION POLICIES
  (NOT-94-331)
  National Institute of Allergy and Infectious Diseases
  

• SUPPORT FOR MENTORED CAREER AWARDS (K20, K21) AND EXPEDITED REVIEW
  (NOT-94-332)
  National Institute on Drug Abuse
  

• SUPPORT FOR NATIONAL RESEARCH SERVICE AWARDS
  (NOT-94-333)
  National Institute on Drug Abuse
  

• COLPOSCOPY QUALITY CONTROL GROUP FOR THE ASCUS/LSIL CLINICAL MANAGEMENT TRIAL
  (NOT-94-342)
  National Cancer Institute
  

• HPV QUALITY CONTROL GROUP FOR THE ASCUS/LSIL CLINICAL MANAGEMENT TRIAL
  (NOT-94-343)
  National Cancer Institute
  

• MUCOSAL PATHOGENS RESEARCH UNITS
  (NOT-94-344)
  National Institute of Allergy and Infectious Diseases
  

• PATHOLOGY QUALITY CONTROL GROUP FOR THE ASCUS/LSIL CLINICAL MANAGEMENT TRIAL
  (NOT-94-345)
  National Cancer Institute
  

• POTENTIAL FOR ENVIRONMENTAL AND THERAPEUTIC AGENTS TO INDUCE IMMUNOTOXICITY
  (NOT-94-346)
  National Institute of Environmental Health Sciences
  

• RANDOMIZED TRIAL ON CLINICAL MANAGEMENT OF ASCUS AND LSIL OF THEUTERINE CERVIX - CLINICAL CENTERS
  (NOT-94-347)
  National Cancer Institute
  

• TARGETING ORAL HEALTH PROMOTION IN A MINORITY COMMUNITY: FEASIBILITY STUDY
  (NOT-94-348)
  National Institute of Dental and Craniofacial Research
  

• HEALTH SERVICES RESEARCH ON ALCOHOL-RELATED PROBLEMS
  (RFA-AA-95-001)
  National Institute on Alcohol Abuse and Alcoholism
  
  

• TROPICAL MEDICINE RESEARCH CENTERS
  (RFA-AI-95-002)
  National Institute of Allergy and Infectious Diseases
  
  

• MECHANISMS UNDERLYING IMMUNOTHERAPY TRIALS IN AUTOIMMUNITY
  (RFA-AI-95-003)
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Diabetes and Digestive and Kidney Diseases
  
  

• MATERNAL ANTIBODIES FOR PASSIVE INFANT IMMUNIZATION
  (RFA-AI-95-004)
  National Institute of Allergy and Infectious Diseases
  
  

• ORAL HEALTH RESEARCH CLINICAL CORE CENTERS
  (RFA-DE-95-001)
  National Institute of Dental and Craniofacial Research
  
  

• NATIONAL GENE VECTOR LABORATORIES
  (RFA-RR-95-002)
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Diabetes and Digestive and Kidney Diseases
  
  

• INTERNATIONAL RESEARCH AND TRAINING IN POPULATION AND HEALTH
  (RFA-TW-95-002)
  John E. Fogarty International Center
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  
  

• INTERNATIONAL TRAINING AND RESEARCH IN ENVIRONMENTAL AND OCCUPATIONAL HEALTH
  (RFA-TW-95-003)
  John E. Fogarty International Center
  National Institute of Environmental Health Sciences
  
  

• AIDS, DRUG ABUSE AND NEUROBIOLOGY
  (PA-95-005)
  National Institute on Drug Abuse
  
  
  

• BIOLOGY OF THE MENOPAUSE: CHANGE OF OVARIAN FUNCTION
  (PA-95-006)
  National Institute on Aging
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Diabetes and Digestive and Kidney Diseases
  
  
  

• SMALL GRANT PROGRAM FOR THE NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS
  (PA-95-007)
  National Institute on Deafness and Other Communication Disorders
  
  
  

  Past Tables of Contents

Department of Health and Human Services

National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892